Related Experiment Video
Updated: Feb 10, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
The expanding roles of microRNAs in kidney pathophysiology
Valérie Metzinger-Le Meuth1, Ophélie Fourdinier2, Nathalie Charnaux1
1INSERM U1148, Laboratory for Vascular Translational Science (LVTS), UFR SMBH, Université Paris 13, Bobigny, France.
Abstract:
MicroRNAs (miRNAs) are short single-stranded RNAs that control gene expression through base pairing with regions within the 3'-untranslated region of target mRNAs. These small non-coding RNAs are now increasingly known to be involved in kidney physiopathology. In this review we will describe how miRNAs were in recent years implicated in cellular and animal models of kidney disease but also in chronic kidney disease, haemodialysed and grafted patients, acute kidney injury patients and so on. At the moment miRNAs are considered as potential biomarkers in nephrology, but larger cohorts as well as the standardization of methods of measurement will be needed to confirm their usefulness. It will further be of the utmost importance to select specific tissues and biofluids to make miRNAs appropriate in day-to-day clinical practice. In addition, up- or down-regulating miRNAs that were described as deregulated in kidney diseases may represent innovative therapeutic methods to cure these disorders. We will enumerate in this review the most recent methods that can be used to deliver miRNAs in a specific and suitable way in kidney and other organs damaged by kidney failure, such as the cardiovascular system.
Insights
MicroRNAs (miRNAs) show promise as biomarkers for kidney diseases. Further research is needed to standardize measurement and explore miRNA-based therapies for kidney and cardiovascular conditions.
Area of Science:
- Molecular Biology
- Nephrology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression.
- miRNAs play a crucial role in kidney physiopathology.
- Their involvement spans various kidney disease models and patient groups.
Purpose of the Study:
- To review the role of miRNAs in kidney diseases.
- To discuss their potential as biomarkers in nephrology.
- To explore innovative miRNA-based therapeutic strategies.
Main Methods:
- Literature review of miRNA involvement in kidney disease.
- Analysis of miRNA roles in cellular and animal models.
- Examination of miRNA implications in patient cohorts (CKD, AKI, hemodialysis, transplant).
Main Results:
- miRNAs are implicated in diverse kidney disease contexts.
- Current evidence suggests miRNAs as potential diagnostic and prognostic biomarkers.
- Challenges include cohort size and method standardization for clinical utility.
Conclusions:
- miRNAs hold significant potential as biomarkers in nephrology.
- Standardization of measurement and selection of appropriate biofluids are critical.
- Targeted modulation of deregulated miRNAs offers innovative therapeutic avenues for kidney and related organ damage.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
MicroRNAs
MicroRNAs
Kidney Structure
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Hypertension II: Pathophysiology

